Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections

    Dermatological conditions

    The latest learning and CPD content on dermatological conditions. Under ‘Other resources’ you will find all our other content related to dermatological conditions.

    CPD and Learning

    Case based learning acne

    Case-based learning: acne vulgarisSubscription

    21 JUN 2019By

    Causes, diagnosis and management options for a range of patients, including those with mild or moderate acne.

    Early lesions from Stevens–Johnson syndrome

    Stevens–Johnson syndrome and toxic epidermal necrolysisSubscription

    10 MAY 2019By , , , , , ,

    Practical guidelines for the treatment and management of Stevens–Johnson syndrome and toxic epidermal necrolysis, rare but life-threatening conditions that are normally caused by drugs or infections.

    Plaque type psoriasis

    Assessment and management of psoriasis in adults in primary careSubscription

    6 MAR 2018By

    Psoriasis is a complex, multifactorial, inflammatory disease associated with a significantly impaired quality of life. Around 80% of patients with plaque psoriasis have mild-to-moderate disease that is amenable to treatment in primary care, particularly through pharmacy, with topical therapies.

    Chickenpox rash close up

    Rashes in childrenSubscription

    13 JUN 2017By ,

    Rashes in children are common and may be difficult to differentiate by appearance alone, therefore, it is important to consider the entire clinical presentation in order to make the appropriate diagnosis.

    Urticaria rash on the upper chest of a woman

    Chronic spontaneous urticaria: clinical features, diagnosis and managementSubscription

    14 JUL 2016By , Runa Ali

    Defined as the non-inducible recurrence of wheals, angioedema or both for six weeks or more, chronic spontaneous urticaria is a difficult to diagnose and debilitating skin condition. Pharmacists should be aware of the clinical features in order to identify and manage this condition effectively.

    Warts and verrucas are common viral skin infections, affecting around 7–12% of the population at any one time, and are more common in children. They are caused by the human papilloma virus (HPV). In the image, micrograph of a common wart

    Warts and verrucas: assessment and treatmentSubscription

    9 JUN 2015By ,

    Lesions caused by human papilloma virus often do not require treatment, but need to be assessed to rule out more serious conditions.

    Burn is an injury caused by thermal (heat), electrical, chemical or radiation energy. In the image, a close up of a third-degree burn

    Burns: assessment and treatmentSubscription

    28 APR 2015By , ,

    Quick action is required with burns to minimise tissue damage and prevent infection.

    Hidradenitis suppurativa

    Hidradenitis suppurativaSubscription

    5 JUL 2014By

    Although there is no cure for this painful condition, pharmacists can play a key role in its management.

    Other resources

    Acne, close up woman's face

    Spironolactone may be effective alternative to antibiotics for adult acne in womenSubscription

    12 JUL 2018

    Researchers investigating treatment failure rates between spironolactone and oral tetracyclines have found no a significant difference, suggesting they may be equally effective.

    Acne scars on back

    Innovation in acne treatment is long overdue but the treatment pipeline looks promisingSubscription

    25 OCT 2017By

    Current treatments for acne are effective but regimens are complex and side effects are common. Better understanding of the pathology of acne is leading to identification of new, safer, treatment targets, and dermatologists and researchers in the field are excited about the pipeline.

    Hand with psoriasis

    Research identifies potential target for treating inflammatory skin diseasesSubscription

    22 SEP 2017

    Targeting Ripk1 could be an effective treatment for skin conditions such as eczema and psoriasis, a study finds.

    Abscess wound after cleaning

    Antibiotics increase cure rate from small skin abscesses compared with drainage aloneSubscription

    28 JUL 2017

    The role of antibiotics in treating small skin abscesses, including those infected with methicillin-resistant Staphylococcus aureus, is currently unclear, with some clinicians opting to simply drain abscesses without antibiotics.

    Vitamin D3 capsules

    High-dose vitamin D counteracts sunburn damageSubscription

    25 JUL 2017

    A double-blinded, placebo-controlled interventional trial reveals high-dose vitamin D3 as a potent modulator of experimental sunburn induced by simulated solar radiation.

    Close up of newborn baby's face with eczema

    Antibiotics not always necessary for paediatric atopic dermatitisSubscription

    31 MAR 2017

    Antibiotics are frequently prescribed for the treatment of acute flares of atopic dermatitis to help reduce the colonisation of Staphylococcus aureus on the skin.

    Micrograph of human skin

    Atopic dermatitis: dupilumab and crisaborole could herald a new era in treatmentSubscription

    23 FEB 2017By

    Atopic dermatitis can have a devastating effect on quality of life, but there have been no major changes to the way it has been treated for over 15 years. Now, two new therapies — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease — could herald a new era in the treatment of this distressing condition.

    Infographic showing how dupilumab works

    Atopic dermatitis: emerging and current treatments Subscription

    23 FEB 2017By

    Atopic dermatitis affects up to 30% of children and 10% of adults, and is common in both developed and developing countries. Two new medicines on the brink of entering the market — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease — could herald a new era in the management of this condition, which has seen no major changes to the way it has been treated for over 15 years.

    Revalidation

    Pharmacists and pharmacy technicians can find guidance from The Pharmaceutical Journal on completing the relevant records to meet the General Pharmaceutical Council requirements, as well as support on the scope of activity that could be included in these records here.